Bank Of Montreal (BMO) Stock News

BMO Financial Group announced significant executive appointments effective July 7, 2025, aimed at strengthening client service and supporting growth across Canada and the US. Key appointments include Aron Levine as Group Head and President of BMO US, bringing three decades of banking experience and impressive track record of growing assets from $60B to $500B. Nadim Hirji becomes Vice-Chair of BMO Commercial Banking, while Ernie Johannson plans to retire in 2026 and transitions to Senior Advisor. Sharon Haward-Laird is appointed Group Head of Canadian Commercial Banking and North American Shared Services, Mat Mehrotra becomes Group Head of Canadian Personal & Business Banking, and several other strategic appointments were made to streamline decision-making and improve profitability. The restructuring includes combining US Personal & Business Banking, Commercial Banking, and Wealth Management operations to optimize ROE and enhance service delivery.

Bank of Montreal (BMO) announced a ticker symbol change for its MicroSectors FANG+ 3× Leveraged ETNs, transitioning from FNGB to FNGU on NYSE Arca effective June 24, 2025. These ETNs, due February 17, 2045, are designed as sophisticated daily trading tools offering 3x leveraged exposure to the NYSE FANG+ Index. BMO emphasizes these instruments are not meant for buy-and-hold strategies due to their daily leverage reset mechanism, which can lead to significant performance divergence from the underlying index over time. The ETNs carry substantial risk and are only suitable for sophisticated investors who actively monitor and understand leveraged ETN dynamics.

BMO successfully concluded its first North American BMO Walks for Good campaign, raising nearly $2.4 million CAD for mental health organizations. Almost 13,000 participants, including BMO employees, friends, and family members, participated in walks across multiple cities in May 2025. The campaign supported Kids Help Phone (KHP) in Canada and the National Alliance on Mental Illness (NAMI) in the US. BMO has been a long-term partner of KHP since 1989, committing over $21.4 million CAD to their Feel Out Loud campaign. In the US, BMO has donated over $320,000 USD to NAMI since 2024. The initiative aims to provide inclusive mental health support across North America while reducing stigma and fostering meaningful connections.

BMO Financial Group (NYSE:BMO) has announced a dividend increase for the third quarter of fiscal year 2025. The quarterly dividend on common shares will be $1.63 per share, representing a 4 cent (3%) increase from the previous quarter and a 5% increase from the prior year. The dividend will be payable on August 26, 2025, to shareholders of record on July 30, 2025.

Additionally, BMO declared dividends on preferred shares: $0.190875 per share for Series 33 and $0.426 per share for Series 44, both payable on August 25, 2025. Shareholders can participate in the Dividend Reinvestment and Share Purchase Plan to reinvest their cash dividends in common shares, with purchases made on the open market without a discount.

BMO Financial Group reported strong Q2 2025 financial results with reported net income of $1,962 million (up from $1,866 million YoY) and adjusted net income of $2,046 million (up from $2,033 million YoY). The bank's EPS increased to $2.50 from $2.36 YoY, while adjusted EPS rose to $2.62 from $2.59. BMO announced a quarterly dividend increase of 5% YoY to $1.63 per share. The bank maintained a strong CET1 ratio of 13.5% and repurchased 7 million common shares. However, provision for credit losses increased to $1,054 million from $705 million YoY. Performance across segments showed mixed results, with BMO Wealth Management showing growth while Canadian P&C experienced a decline in net income.

BMO is set to host its 20th annual Farm to Market | Chemicals Conference on May 14-15, 2025, at the InterContinental Barclay Hotel in New York. The two-day event will bring together global institutional investors, financial sponsors, and companies from across the food, agriculture, and chemical sectors.

The conference will feature presentations and panel discussions on crucial industry topics, including alternative capital sources, consumer health trends, M&A markets, functional beverages, sustainability strategies, and the impact of GLP1+ therapeutics. BMO's leading analysts will lead discussions with over 100 major companies, including Archer-Daniels-Midland, Bayer, CF Industries, Kroger, and Tyson Foods.

BMO announced the redemption of its MicroSectors FANG+ Index 3× Leveraged ETNs (FNGA) and reminded investors about the availability of its replacement product, FNGB ETNs. The Call Measurement Period for FNGA will run from May 2-8, 2025, with the Call Settlement Date expected on May 15, 2025. The final trading day for FNGA is expected to be May 14, 2025. The new FNGB ETNs, launched on February 19, 2025, offer 3x leveraged exposure to the NYSE FANG+ Index with a discounted fee rate of 0.35% per annum until August 19, 2025, after which it will increase to 0.95%. Both ETNs track an equally-weighted index of 10 high-growth tech stocks, providing daily resetting leverage designed for sophisticated investors' short-term trading strategies.

BMO has announced the redemption of its MicroSectors™ FANG+™ Index 3× Leveraged ETNs (FNGA) and reminded investors about the availability of its replacement product, the FNGB ETNs.

The FNGA ETNs will be redeemed on May 15, 2025, with the last trading day expected to be May 14, 2025. BMO is exercising this call right due to increased costs associated with supporting the leverage, making current fees no longer reflective of market conditions.

The new FNGB ETNs, trading under ticker 'FNGB' since February 20, 2025, offers similar 3x leveraged exposure to the NYSE FANG+® Index. It features a discounted Daily Investor Fee of 0.35% per annum until August 19, 2025, after which it will increase to 0.95% per annum.

Bank of Montreal (BMO) held its Annual Meeting of Shareholders on April 11, 2025, where shareholders elected 13 directors to the company's board. The election results showed strong shareholder support, with all nominees receiving over 94% approval.

Notable results include Brian McManus receiving the highest approval rate at 99.69% of votes, while George A. Cope received the lowest but still strong support at 94.93%. The voting results demonstrated particularly strong confidence in several directors, including Stephen Dent (99.62%), David Harquail (99.61%), and Hazel Claxton (99.55%).